BioAsia to promote innovations in Life Science and Healthcare through ‘Start-up Stage’ in its 17th Edition
·
BioAsia 2020 will showcase about
75 promising start-ups with cutting edge solutions to transform healthcare
·
Over 300 applications already received
till date; Last day for application is January 12, 2020
Asia’s
largest Life-sciences and healthcare forum BioAsia,
will continue to feature a dedicated platform - Start-up Stage in its 17th edition to be held
at Hyderabad between February 17th to 19th February 2020. The Start-up Stage at
BioAsia 2020 will provide a unique opportunity to the most promising start-ups
across India to interact with global industry leaders. Start-up Stage will enable entrepreneurs to
showcase their innovative solutions in the pharma, biotech, life sciences,
health-tech, and med-tech sectors.
Start-up Stage is designed to encourage
innovative collaborations and partnerships between entrepreneurs and industry
leaders / investors. Top 5 start-ups from these 75 shortlisted start-ups will
get an opportunity to present their solution to the leaders from over 50
Nations in attendance at BioAsia in addition to the cash prize. The start-ups
will also get an unmatched opportunity to request exclusive one-to-one meetings
with the participating delegates and be a part of the overall deliberations at
the event. These opportunities would help them to get insights and guidance on
several emerging healthcare challenges and technologies. They will get access
to be a part of all the conferences and sessions at BioAsia 2020.
Interested Start-ups can visit BioAsia 2020 website to apply for
Start-up stage at https://forms.gle/PAR95YquLkB5tMHU8. Selected start-ups will
get free exhibit space, networking opportunity and visibility in the foremost
global conference, among others.
Government of Telangana and BioAsia have partnered with Tech
Mahindra as the lead sponsor for the Start-up stage. Commenting on the Start-up
Stage, Mr. Jayesh Ranjan IAS, Principal Secretary,
Industries & Commerce and Information Technology, Government of
Telangana said, “BioAsia has emerged as one of the
highly regarded life sciences conventions with participation of Who’s who of
the life sciences sector. Vision of the Telangana Government has been to
promote innovation and in line, we have been encouraging innovative solutions
in life sciences and healthcare by start-ups to be showcased as part of this
biggest gathering of life sciences. In the last 5 years of the Start-up stage
at BioAsia, we have constantly worked to encourage and showcase the promising
start-ups and this platform has received an enthusiastic response from the
stakeholders, investor community, etc. We are delighted that the start-ups
recognized in the last few years at BioAsia have been continuously moving up in
the value chain and creating a niche positioning.”
In the last 2 editions of BioAsia’s
Start-Up stage, some of the high potential start-ups recognized and awarded
have been continuously moving up in the value chain creating a niche
positioning. Caredose which was awarded in 2019 edition and offers a
proprietary technology aiding chronic patients in medicine adherence by
providing pre-packaged medication, reminders to consume medication, ability to
reorder, alert a caregiver and relay the adherence data to providers for better
diagnosis has successfully raised a total of USD 300,000 in 2019 itself and
partnered with Abbott Pharmaceuticals to help them with their patient adherence
program. Similarly, Next Big Innovation Lab which developed India’s
first customisable 3D Bioprinter (TRIVIMA), was not only successful in raising
funds from global major MERCK but has also set-up TRIVIMA within Merck’s
R&D lab in Darmstadt, Germany for collaborative R&D. It is also invited
at World Economic Forum to be part of Expert Network in 3D printing and offer
inputs in the area of 3D Bioprinting. Another start-up, Dozee which is a contactless, non-wearable
health-monitoring solution provider has been selected by the Government of
India to represent Indian start-ups at Estonia its solution achieved accuracy
to track heart valve movements, thereby, helping flag cases of heart failure in
advance. Docturnal Private Limited which is a point of care screening
and diagnostics provider of non-invasive and proactive detection of diseases as
also raised funds from Mumbai Angels. Testright which developed
high performance and portable Spectrophotometers was also adjudged the National
winner at ‘Get in the Ring event’ and further represented India in Berlin. The
start-up also received the Patent
for its Holofy technology which is sticker-less hologram technology to
protect Pharma and FMCG products from counterfeiting. It is now working with eminent brands to protect them
from fake products.
To provide an
understanding of the growth drivers and motivating the start-up founders, Mr. Shakthi Nagappan, CEO, BioAsia, said “Start-up Stage has become one of the highlight components of
BioAsia and the platform helps start-ups get unparalled access to the who’s who
of the global life sciences and healthcare industry. We are overwhelmed with
the response from the Start-up community for the event and more than 300
applications have already been received so far. We are also thrilled with the enthusiastic
response from the Life Sciences Industry leaders, Venture capital & Angel
investor community and the corporate M&A teams of leading pharma &
biotech companies.”
Some of the biggest and
influential organizations in the have come joined together for the Start-up
Stage includes Tech Mahindra, Swissnex India, Department of Biotechnology,
BIRAC, Telangana State Innovation Cell, NASSCOM, T-Hub, Research and Innovation
Circle of Hyderabad, Ernst and Young, Endiya Partners, Mumbai Angels, IKP, AIC_CCMB,
Light House Canton, Life Sciences and Healthcare Innovation Forum, yourstory, xpomet
(Germany), among others.
BioAsia 2020 is set to host
eminent global leaders from the life sciences industry including Mr. Vas
Narasimhan (CEO, Novartis), Dr. Carl June (University of Pennsylvania &
CAR-T Expert), Dr. Peter Piot (Director, London School of Hygiene and Tropical
Medicine, and Co-Discoverer of Ebola), Mr. Ajay Piramal (Chairman, Piramal),
Mr. Dilip Sanghvi (Chairman, Sun Pharma), Mrs. Kiran Mazumdar Shaw (CMD,
Biocon), Mr. Satish Reddy (Chairman, Dr. Reddy’s), among others.
We are urgently in need of Female Eggs,Kidney donors, with the sum of $500,000.00,Email: jainhospitalcare@gmail.com or healthc976@gmail.com
ReplyDelete